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DNA methylation plays an important role in gene regulation. 
As such, it is an important intermediate molecular phenotype 
that links genotypes and other macro-level phenotypes and may 
contribute to the missing heritability.1 Despite their prominent 
physiologic role, the genetic determinants of DNA methylation 
patterns are poorly understood. There is evidence of correlation 
between genetic variation at specific loci and the quantitative trait 
of DNA methylation.2-5 Additionally, prior studies6,7 revealed 
that genetic variants at CpG sites (meSNPs) are likely to dis-
rupt the substrate of methylation reactions and thus drastically 
change the methylation status at a single CpG site. However, it 
is unclear if meSNPs represent a major class of methylation-asso-
ciated loci (meQTLs). Moreover, it is unclear if meSNPs modu-
late the methylation status of nearby CpG sites. Most existing 
meQTL studies2-5 are based on relatively small-sized samples and 
low-resolution methylation microarrays, wherein meSNPs are 
sparsely represented. Additionally, current practices of meQTL 
analysis typically exclude probes that contain sequence variants 
to limit misclassification due to alterations in probe hybridiza-
tion.2,3 Recently, we generated high-resolution genotyping and 
epigenetic data from the Genetics of Lipid Lowering Drugs 
and Diet Network (GOLDN),8 yielding a considerable amount 
of meSNPs with information on both genotype and methyla-
tion status. These data enabled us to investigate the impact of 
meSNPs on the methylation status of the CpG site harboring the 
SNP, as well as on surrounding CpG sites.
DNA methylation is an important molecular-level phenotype that links genotypes and complex disease traits. previous 
studies have found local correlation between genetic variants and DNA methylation levels (cis-meQtLs). However, 
general mechanisms underlying cis-meQtLs are unclear. We conducted a cis-meQtL analysis of the Genetics of Lipid 
Lowering Drugs and Diet Network data (n = 593). We found that over 80% of genetic variants at CpG sites (meSNps) are 
meQtL loci (P value < 10−9), and meSNps account for over two thirds of the strongest meQtL signals (P value < 10−200). 
Beyond direct effects on the methylation of the meSNp site, the CpG-disrupting allele of meSNps were associated with 
lowered methylation of CpG sites located within 45 bp. the effect of meSNps extends to as far as 10 kb and can contribute 
to the observed meQtL signals in the surrounding region, likely through correlated methylation patterns and linkage 
disequilibrium. therefore, meSNps are behind a large portion of observed meQtL signals and play a crucial role in the 
biological process linking genetic variation to epigenetic changes.
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We used CD4+ T-cells harvested from frozen buffy coat sam-
ples isolated from peripheral blood for methylation measurement. 
We used CD4+ T-cells simply due to their abundance and physi-
ological role in the immune response. While that ensures higher 
validity of findings, our results may not be generalizable to other 
cell populations. After genotype imputation and quality control 
(see Supplemental Methods), we had data for 461 281 CpGs of n 
= 593 GOLDN participants. All participants had previously been 
genotyped at 906 600 loci using the Affymetrix Genome-Wide 
Human SNP Array 6.0, as described in prior publications.9,10 
MACH software (Version 1.0.16) was used to impute non-
genotyped SNPs using HapMap Phase II (release 22, Human 
Genome build 36, hg18) as a reference, resulting genotypes of 
2 529 001 SNPs.
We first performed a genome-wide cis-meQTL analysis of 
GOLDN data. We restricted the analysis to SNP/CpG site pairs 
within 20 kb of each other, and removed the pairs in which the 
SNP was located on the methylation probe as described below, 
yielding 12 347 772 pairs for the final analysis. We used linear 
mixed models, fit using the lmekin function of the Kinship pack-
age in R,11 to regress the methylation level (β value) of a CpG site 
on the genetic variant at a SNP site, adjusting for covariates (age, 
sex, and recruitment center) as fixed effects and family struc-
ture as a random effect. Adjusting top principal components of 
phenotype matrix is an effective approach to reduce experimen-
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We subsequently investigated the potential impact of meSNPs 
on the methylation status of nearby CpG sites, located within 
100 bp. It is notable that the M450K chip only directly measures 
the methylation status at CpG sites of the reference genome, and 
thus only SNPs that disrupting CpG sites are directly observ-
able. To study the potential effect of all CpG-gain SNPs to 
nearby CpG sites, we conducted a bioinformatics annotation 
of all SNPs in the GOLDN and the 1000 Genomes Project 
phase 1 release. All SNPs were classified into four categories in 
terms of changing CpG sites on the reference genome: CpG-
loss, which eliminates a CpG site; CpG-gain, which creates a 
CpG site; CpG-shift, which represents a variant between CCG 
and CGG that shifts the position of a CpG site by 1 bp; and 
CpG-irrelevant. CpG-loss and CpG-gain SNPs are only defined 
relative to the reference genome; both CpG-loss and CpG-gain 
have an allele that disrupts the substrate of methylation and thus 
are likely to be meQTLs. All 812 meSNPs represented on the 
M450K chip and were successfully genotyped in GOLDN are 
either CpG-loss (803, 99%) or CpG-shift (9, 1%). We scanned 
all 39 million SNPs from the 1000 Genomes Project phase 1 
release and all 2.5 million SNPs in the GOLDN imputed vari-
ant set, resulting in the classification of SNPs as shown in Figure 
S3. Overall, we found that 14% of GOLDN SNPs are CpG-loss 
and 14% are CpG-gain. Similar proportions were observed in 
the 1000 Genomes Project Phase 1 SNPs (Fig. S3).
Although the methylation measurements at CpG-gain SNPs 
and many of the CpG-loss SNPs are not directly observed, 
we reasoned that they likely follow the same pattern as the 
812 CpG-loss SNPs discussed above. To investigate the effect 
of meSNPs to the methylation at immediate nearby sites, we 
looked for meQTLs (P < 10−9) between 701 CpG-gain or 861 
CpG-loss SNPs with allele frequency between 5% and 95% 
represented in the GOLDN genotype set and CpG sites within 
100 bp (but not at the SNP directly) with M450K measure-
ments in Infinium II chemistry, and found 1562 such pairs. 
Through a linear regression of the effect sizes of these meQTL 
and the distance between the SNP-CpG pairs, we found that, 
for each CpG-disrupting allele, the methylation of CpG sites at 
very close distance is also lowered for about 2% (P value = 3 × 
10−11 for the intersect), but the effect is diminishes to flat and 
even a slight elevation beyond 60 bp (P value = 4.0 × 10−10 for 
the slope) (Fig. 2). This result suggests that a CpG-changing 
SNP can affect not only the methylation status of its own CpG 
site, but also the methylation patterns surrounding it at very 
close distance. However, while this may point to an interesting 
methylation regulation mechanism, additional investigations 
are warranted to rule out potential technical artifacts such as 
local hybridization competition.
Finally, we investigated whether meSNPs may explain 
meQTL signals at surrounding sites located within 10 kb. Not 
all meQTL signals are due to independent association signals. 
In particular, we observe that meQTL signals show a prominent 
correlation pattern (Fig. 2B). We therefore hypothesize that, 
in the neighborhood of a meSNP with genotype X and CpG 
methylation Y, the meQTL signal between genotype X' and 
CpG methylation Y is due to their respective correlations to the 
trait analysis.12,13 Therefore, we adjusted for the top four principal 
components as the proportion of explained variance in methyla-
tion drops off sharply after the fourth principal component. We 
identified 465 649 cis-meQTL signals, defined as any SNP/CpG 
site pair within 20 kb distance of each other that reached the 
nominal P-value cutoff of 10−9. We used the significant associa-
tion of random SNP/CpG site pairs as an upper bound of false 
discoveries, a strategy used in expression QTL analysis.12 While 
that approach overestimates the true false discovery rate (FDR) 
due to ignoring any potential true trans-meQTLs, it is easier to 
compute and preserve all family structure and covariates. Using 
130 million pairs, we estimated that the nominal P value of 10−9 
as equivalent to the FDR of 0.000 004, and the nominal P value 
of 10−200 as FDR < 7.7 × 10−9 (no random pairs with P < 10−200). 
As expected, these Pvalues far exceed the cutoffs used in previous 
reports2-5 due to the high density of the M450K chip.
Although the M450K chip is not designed for profiling meth-
ylation levels at CpG sites harboring SNPs, valid methylation 
measurements can nevertheless be obtained through careful 
analysis. The M450K chip is known to have a “probe effect,” 
i.e., the SNP/CpG site pair with the SNP on the probe may be 
enriched for meQTLs. While Illumina recommends caution for 
the probe effect when the SNP is within 10 bp of the interrogated 
CpG site, we observed that the probe effect is present through-
out the entire length of the 50 bp probe (Fig. S2). Therefore, 
we removed all pairs with SNPs on the probe from this analysis. 
However, it is important to note that, among the two chemis-
tries in the M450K platform—Infinium I and Infinium II—only 
Infinium I measurements, whose probe covers the entire CpG 
dinucleotide, are subject to the probe effects of SNPs at the CpG 
site itself. For the 1 bp extension of Infinium II chemistry, posi-
tion 0 on a forward probe and position 1 on a reverse probe do 
not hybridize to interrogated DNA and thus still provide valid 
methylation measurements (see Supplemental Methods). After 
excluding probes that matched to non-unique positions in the 
hg19 genome as well as the 95 sites located on Infinium I probes, 
we first investigated these 812 meSNPs for which both methyla-
tion level and genotype were directly observed or imputed. See 
Table S1 for a complete list of these meSNPs.
Many of the most statistically significant meQTLs were co-
localized to the 812 meSNPs (Fig. 1). 85% of meSNPs interro-
gated by forward strand probes and 92% by reverse strand probes 
were cis-meQTLs (Fig. 1). These SNPs were strongly negatively 
associated with the methylation of the CpG site (Table 1). Cis-
meQTL signals remained strong at 1–3 bp away from the CpG 
site (20–45%), but sharply decreased to < 0% for most sites >3 bp 
away from the CpG site. The signal attenuated to approximately 
5% of pairs separated by the distance of 1000 bp and 3% for 
pairs at 20 000 bp, still well above the 0.0003% for random pairs 
in the entire genome. Interestingly, we observed that pairs with 
SNPs on the probe do have inflated meQTL signals (Fig. S2). 
Absence of a significant meQTL signal at meSNPs was mainly 
due to the methylation being already depleted for the CpG allele 
or to very low genetic variation. Therefore, we conclude that 
meSNPs indeed disrupt the methylation and that the M450K 
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We found a considerable attenuation of meQTL signals sur-
rounding meSNPs (Fig. 2C vs. B). In the 10 kb neighborhood of 
812 observed meSNPs, the total numbers of meQTLs decreased 
by 32.8%, from 8017 to 5384 after the adjustment. Given the 
genome-wide distribution of meSNPs, most of which are not 
directly observed on the M450K chip, we estimate that meQTLs 
at meSNPs may explain a large portion of observed cis-meQTL 
signals.
Overall, our analysis provides the first genome-wide profil-
ing of methylation changes at and surrounding SNPs. These 
meSNP pair X and Y: X' to X by linkage disequilibrium, Y' to 
Y by methylation correlation. Unlike standard mediation analy-
ses, we are not claiming a chain of causative links, but rather 
to test if the associations X' to Y' and X to Y are independent. 
Instead of running a full mediation analysis,14 we conducted 
a partial mediation analysis, i.e., the conditional regression of 
Y' to X' given Y, in addition to the pairwise meQTL analysis. 
If they are truly independent associations, regressing Y' to X' 
conditional on Y should not eliminate the significant meQTL 
association between Y' and X'.
Table 1. Summary of 812 cis-meQtLs at meSNps probed by infinium ii chemistry
Strand Position within CpG Ref Alt Count Mean −log10P val Mean effect size β %meQTL*
f 0 C A 6 102.0 −0.207 83.33%
f 0 C G 11 95.2 0.151 90.91%
f 0 C t 79 108.3 −0.229 84.81%
r 1 G A 606 115.4 −0.216 92.41%
r 1 G C 48 74.5 0.111 87.50%
r 1 G t 62 103.1 −0.217 88.71%
*% of pairs with P < 10−9. See Supplemental Methods for an interpretation of the effect sizes.
Figure 1. meSNps are enriched for the most significant meQtL signals. (A) the percent of CpG sites that are meSNp, within 20 kb neighborhood of a 
meSNp (“neighborhood”), or “all others.” for each CpG site, the measure of its meQtL signals is the maximum of −log10(P value) of its SNp/CpG pairs. 
for each bin of −log10(P value), we plotted the percent of each type of CpG sites. (B) proportion of SNp/CpG site pairs with meQtL signal, defined as P 
value < 10−9, stratified by distance. 96 meSNps at the position 0 and 716 meSNps at position 1 are represented. on average, 138 non meSNp pairs per 

























disease phenotypes. We conclude that meSNPs may be a crucial 
class of variants to be considered in interpretation of genomic and 
epigenomic association results.
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meSNPs contribute to the strongest methylation QTL signals 
as they disrupt the methylation status at CpG sites. Moreover, 
meSNPs also modulate methylation status at nearby CpG sites 
and a large proportion of variability in DNA methylation can 
be explained by genetic variation at the CpG site itself. Our data 
suggest a potential biological mechanism underlying associations 
between common genetic variants, epigenetic processes, and 
Figure 2. Effect of meSNps on methylation at nearby CpG sites. (A) Near-range effect of meSNps. for 1,562 CpG-changing (including CpG-loss and 
CpG-gain) SNps that have significant meQtL (P value < 10−9) to a CpG site within 100 bp, we plot their SNp-CpG distance (X-coordinate) vs. their meQtL 
effect sizes (Y-coordinate). Both CpG-loss and CpG-gain SNp genotypes are oriented such that the CpG-carrying allele is coded as 0 and the non-CpG-
carrying allele is coded as 1. (B and C) Effect of meSNp beyond immediate neighborhood. We plotted the distribution of cis-meQtL signals surround-
ing 812 meSNps in the GoLDN data, before (B) and after (C) adjusting for meSNps. the center is the location of the meSNps. the X-axis represents the 
relative position of the SNp to the central meSNps, organized into 101 equal-sized bins, each covering 198 bp. the Y-axis represents similar bins for the 
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